Lighthouse Investment Partners’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,407
Closed -$418K 792
2025
Q4
$418K Buy
+2,407
New +$438K 0.01% 634
2024
Q4
Sell
-4,487
Closed -$697K 534
2024
Q3
$697K Sell
4,487
-31,070
-87% -$4.64M 0.03% 350
2024
Q2
$4.87M Sell
35,557
-19,568
-35% -$2.68M 0.19% 138
2024
Q1
$7.34M Buy
+55,125
New +$7.15M 0.34% 80
2023
Q4
Sell
-39,024
Closed -$4.76M 318
2023
Q3
$4.76M Buy
+39,024
New +$5.2M 0.19% 120

Other funds holding DGX

Lighthouse Investment Partners's DGX Position: Q1 2026 in Review

Lighthouse Investment Partners sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 2,407 shares — an estimated $418K sold.

Lighthouse Investment Partners first reported a position in DGX in Q3 2023 and held it in 5 quarters. The position peaked at $7.34M in Q1 2024. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Lighthouse Investment Partners reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
  • Lighthouse Investment Partners sold 2,407 Quest Diagnostics shares in Q1 2026, an estimated $418K.
  • Lighthouse Investment Partners first reported a position in Quest Diagnostics in Q3 2023 and held it in 5 quarters.
  • Lighthouse Investment Partners's Quest Diagnostics position peaked at $7.34M in Q1 2024.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.